Gestational diabetes mellitus (GDM) is a common metabolic disorder that affects pregnant women. It is associated with an increased risk of maternal and neonatal morbidity, making its effective management crucial for optimizing outcomes. This guide aims to provide healthcare professionals with a comprehensive approach towards GDM management.
Early detection of GDM is paramount in preventing adverse outcomes. It is recommended to screen all pregnant women between 24-28 weeks of gestation using an oral glucose tolerance test. High-risk women should be screened as early as the first prenatal visit.
Medical Nutrition Therapy (MNT) is the cornerstone of GDM management. It involves the intake of a balanced diet, maintaining regular meal timings, and monitoring carbohydrate intake. MNT should be individualized according to the patient's nutritional needs and lifestyle.
Regular physical activity is beneficial in managing GDM. It aids in glucose regulation and reduces insulin resistance. Moderate-intensity exercises, such as brisk walking, are recommended for at least 30 minutes a day, most days of the week.
If MNT and physical activity fail to achieve glycemic control, pharmacological intervention becomes necessary. Insulin therapy is considered the gold standard, but oral hypoglycemic agents like metformin and glyburide are also options.
Women with GDM are at risk of developing type 2 diabetes postpartum. Therefore, it is essential to conduct a 75g oral glucose tolerance test at 6-12 weeks postpartum and continue regular follow-ups to monitor glucose levels.
Managing GDM effectively requires a comprehensive approach, including early detection, lifestyle modifications, pharmacological management, and postpartum follow-up. By adhering to these guidelines, healthcare professionals can optimize outcomes for both the mother and the newborn.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
5.
Males with early-onset colorectal cancer are at risk, according to a study.
1.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
4.
Innovative Breakthroughs in Hematology for Modern Medicine
5.
Precision Erythropoietic Modeling for Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Role of Screening in Cancer Prevention
2.
Innovations in Hematology
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation